Form 4: Alpha Tau Medical CFO Sells Shares
Insider Transaction (Form 4)
Raphi Levy, Chief Financial Officer of Alpha Tau Medical Ltd., sold 17,730 shares of common stock on August 11, 2026 for $14.00 per share.
Summary
- Option exercise/conversion: acquired 17,730 Ordinary Shares at $2.98 ($52,835) on August 11, 2026; holds 107,910 after (Direct).
- Open-market sale: disposed of 17,730 Ordinary Shares at $14.00 ($248,277) on August 11, 2026; holds 90,180 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $248,277 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Raphi Levy — Officer (Chief Financial Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-11 | Option exercise/conversion | Ordinary Shares | 17,730 | $3 | $52.8K | 107,910 |
| 2026-08-11 | Open-market sale | Ordinary Shares | 17,730 | $14 | $248.3K | 90,180 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-11 | Option exercise/conversion (17,730 shares) |
| 2026-08-11 | Open-market sale (17,730 shares) |
Keywords
insider transaction, Form 4, DRTS, Alpha Tau Medical Ltd., bearish, Raphi Levy
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.